These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 7586258)

  • 1. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
    Holubarsch C; Schneider R; Pieske B; Ruf T; Hasenfuss G; Fraedrich G; Posival H; Just H
    Circulation; 1995 Nov; 92(10):2904-10. PubMed ID: 7586258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inotropic interventions on the force-frequency relation in the human heart.
    Bavendiek U; Brixius K; Münch G; Zobel C; Müller-Ehmsen J; Schwinger RH
    Basic Res Cardiol; 1998; 93 Suppl 1():76-85. PubMed ID: 9833134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
    Böhm M; Mittmann C; Schwinger RH; Erdmann E
    Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of antiarrhythmic compounds: intrinsic effects and autonomic modulation.
    Hoffmeister HM; Beyer ME; Seipel L
    Am J Cardiol; 1997 Oct; 80(8A):24G-30G. PubMed ID: 9354409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inotropic and haemodynamic effects of d- and d,l-sotalol: comparison with other antiarrhythmics.
    Seipel L; Hoffmeister HM
    Eur Heart J; 1993 Nov; 14 Suppl H():36-40. PubMed ID: 7904937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
    Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.
    Moniotte S; Kobzik L; Feron O; Trochu JN; Gauthier C; Balligand JL
    Circulation; 2001 Mar; 103(12):1649-55. PubMed ID: 11273992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term pretreatment with isoproterenol on inotropic responsiveness to alpha-adrenoceptor stimulation: study in isolated perfused rat hearts.
    Silva CO; Monteiro-Filho WO; Duarte GP; Lahlou S
    J Pharm Pharmacol; 2001 Feb; 53(2):233-42. PubMed ID: 11273021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class III antiarrhythmic action linked with positive inotropy: effects of the d- and l-isomer of sotalol on isolated rat atria at threshold and suprathreshold stimulation.
    Tande PM; Refsum H
    Pharmacol Toxicol; 1988 May; 62(5):272-7. PubMed ID: 3413029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic basis of the antiarrhythmic and hemodynamic effects of sotalol.
    Antonaccio MJ; Gomoll A
    Am J Cardiol; 1993 Aug; 72(4):27A-37A. PubMed ID: 8346723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
    Bristow MR; Ginsburg R; Umans V; Fowler M; Minobe W; Rasmussen R; Zera P; Menlove R; Shah P; Jamieson S
    Circ Res; 1986 Sep; 59(3):297-309. PubMed ID: 2876788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antifibrillatory effects of d- and dl-sotalol in normal and ischaemic ventricular muscle of the cat.
    Kwan YW; Solca AM; Gwilt M; Kane KA; Wadsworth RM
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):233-8. PubMed ID: 1689418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cantharidin on force of contraction and phosphatase activity in nonfailing and failing human hearts.
    Linck B; Boknik P; Knapp J; Müller FU; Neumann J; Schmitz W; Vahlensieck U
    Br J Pharmacol; 1996 Oct; 119(3):545-50. PubMed ID: 8894176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inotropic beta-blocking potency (pA2) and partial agonist activity of propranolol, practolol, sotalol and acebutolol.
    Lewis MJ; Grey AC; Henderson AH
    Eur J Pharmacol; 1982 Dec; 86(1):71-6. PubMed ID: 6130956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
    Maack C; Böhm M; Vlaskin L; Dabew E; Lorenz K; Schäfers HJ; Lohse MJ; Engelhardt S
    Circulation; 2003 Jul; 108(3):348-53. PubMed ID: 12847069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
    Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
    J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol.
    Groh WJ; Gibson KJ; McAnulty JH; Maylie JG
    Circulation; 1995 Jan; 91(2):262-4. PubMed ID: 7805226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
    Bundkirchen A; Brixius K; Bölck B; Schwinger RH
    J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium.
    Müller-Ehmsen J; Brixius K; Schwinger RH
    J Cardiovasc Pharmacol; 1998 May; 31(5):684-9. PubMed ID: 9593067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.